Peg-Interferon Alpha 2b Combined With Two Intravenous Broadly HIV-1 Neutralizing Antibodies 3BNC117 and 10-1074 (BEAT-2)

NCT03588715 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

15

Enrollment

OTHER

Sponsor class

Conditions

HIV
HIV/AIDS
HIV-1 Infection

Interventions

DRUG: Pegylated Interferon alpha 2b (peg-IFN-α2b)
DRUG: 3BNC117 + 10-1074

Sponsor

Luis Montaner

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]